Answers are grounded in this paper and cite their sources.
Investigates benzocaine removal in wastewater, suggesting improved treatment methods with resin technology.
Pharmaceutical residues continue to increasingly contaminate water systems at a global level, and conventional wastewater treatment plants are unable to completely remove these emergent compounds. This study investigates the benzocaine adsorption from aqueous solutions onto Amberlite XAD-7 (X7) resin, with emphasis on quantitative performance metrics and mechanistic understanding. Adsorption occurred rapidly, reaching equilibrium within 60 min, with a maximum adsorption capacity (Qe) of 140 mg/g and a Langmuir monolayer capacity of 147 mg/g. Experimental parameters strongly influenced X7 performance: resin dosage (0.01–0.05 g) and agitation speed (25–200 rpm) enhanced removal efficiency from 10% to 99.9%, while pH variation (5–9) had a negligible effect, confirming a predominantly hydrophobic, non-ionic adsorption mechanism. Equilibrium data are best described by the Langmuir model (R2 = 0.9920, b = 5.2 L/mg, RL = 0.0003), indicating highly favorable monolayer adsorption, while kinetic behavior is described by the pseudo-second-order (PSO) model. FTIR-ATR analysis confirms benzocaine retention through characteristic shifts in aromatic, amine, and ester bands. TG/DSC measurements prove the thermal stability of X7 and the incorporation of benzocaine within the polymeric matrix. Desorption efficiencies ranged from 40% (NaOH) to 97% (HCl-ethanol mixture), demonstrating that X7 was regenerated under the tested conditions with a single cycle. Overall, X7 exhibits high capacity, robustness, and recyclability, highlighting its strong potential for efficient benzocaine removal from contaminated wastewater.
No takes yet. Share an insight, caveat, or question.
Marin et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: